MedPath

MS PATHS Normative Sub-Study

Completed
Conditions
Healthy Volunteer
Registration Number
NCT02996084
Lead Sponsor
Biogen
Brief Summary

The primary objective of this study is to determine the normative range of brain volume and brain volume change in healthy control (HC) participants whose age, race, and gender distribution is approximately matched to the age, race, and gender distribution of patients with Multiple Sclerosis (MS) enrolled in Study 888MS001. The secondary objective is to use the results of the primary endpoint to ensure consistency of brain volume measurements across MS PATHS centers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
246
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brain volumeEvery 12 months up to 3 years

Measured by using magnetic resonance imaging (MRI) scans

Brain volume changeEvery 12 months up to 3 years

Measured by using MRI scans

Secondary Outcome Measures
NameTimeMethod
Development of models to calibrate brain volume measurements between centers, if necessaryUp to 3 years

Measured by using MRI scans

Trial Locations

Locations (6)

Johns Hopkins University

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

The Cleveland Clinic Foundation

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

Multiple Sclerosis Centre of Catalonia (Cemcat) Vall d'Hebron Hospital

πŸ‡ͺπŸ‡Έ

Barcelona, Spain

University Hospital Carl Gustav Carus Dresden

πŸ‡©πŸ‡ͺ

Dresden, Germany

Washington University

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

University of Rochester Medical Center

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath